Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels
Lewis, B.; Chait, A.; Wootton, I.D.; Oakley, C.M.; Krikler, D.M.; Sigurdsson, G.; February, A.; Maurer, B.; Birkhead, J.
Lancet 1(7849): 141-146
1974
ISSN/ISBN: 0140-6736 PMID: 4129717 Document Number: 73836
Document emailed within 1 workday
Related Documents
Sattar, N.; Welsh, P.; Sarwar, N.; Danesh, J.; Di Angelantonio, E.; Gudnason, V.; Davey Smith, G.; Ebrahim, S.; Lawlor, D.A. 2010: NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study Atherosclerosis 209(1): 295-299Li, Z.X. 1982: Serum high density lipoprotein cholesterol (HDL-C) level and its regulating factors in healthy subjects and patients with coronary heart disease Zhonghua Yi Xue Za Zhi 62(1): 13-17
Rywik, S.; Kuźmińska, A.; Bańkowska, M.; Wagrowska, H.; Mering, E.; Magdoń, M.; Kozek, E.; Mizera, R.; Idzior, B.; Nowakowska, J. 1979: The prevalence of ischaemic heart disease in chosen subgroups of the Polish population and relationship between the prevalance and risk factors Przeglad Lekarski 36(10): 729-735
Holtzman, E.; Rosenthal, T.; Goldbourt, U.; Segal, P. 1984: Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status Israel Journal of Medical Sciences 20(12): 1169-1176
Meimanaliev, T.S.; Shleifer, E.A.; Aitbaev, K.A.; Aitmurzaeva, G.T.; Gil'fanova, V.Sh.; Podgurskaya, L.P.; Abdurasulov, K.D.; Finger, E.M.; Ismailova, C.S.; Koshaliev, E.K. 1991: Prevalence of ischaemic heart disease risk factors among the male population in Frunze aged 40-59 years and results of a five-year prevention programme Cor et Vasa 33(6): 451-457
Oganov, R.G.; Zhukovskii, G.S.; Glasunov, I.S.; Perova, N.V.; Chakhava, M.V.; Deev, A.D.; Konstantinov, V.V.; Akhmeteli, M.A.; Vinogradova, D.A. 1987: Changes in the incidence of ischaemic heart disease (IHD) risk factors among a male population without IHD aged 40-59 years after eight-year period (from 1975-1977 to 1983-1984) Cor et Vasa 29(6): 406-411
Sigfusson, N.; Sigvaldason, H.; Steingrimsdottir, L.; Gudmundsdottir, I.I.; Stefansdottir, I.; Thorsteinsson, T.; Sigurdsson, G. 1991: Decline in ischaemic heart disease in Iceland and change in risk factor levels Bmj 302(6789): 1371-1375
Haviar, V.; Riecanský, L.; Kusá, O.; Luknárová, O. 1972: Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease Cor et Vasa 14(3): 188-196
Glazunov, I.S.; Baubinene, A.V.; Domarkene, S.B.; Grabauskas, V.I.; Kuzminskis, V.V.; Prokhorskas, R.P.; Misjavicene, I.S. 1982: A lowering of the risk of ischaemic heart disease among the population (according to the results of the Kaunas preventive study) Cor et Vasa 24(4): 233-239
Wyndham, C.H.; Seftel, H.C.; Pilcher, G.J.; Baker, S.G. 1987: Prevalence of hypercholesterolaemia in young Afrikaners with myocardial infarction. Ischaemic heart disease risk factors South African Medical Journal 71(3): 139-142
Rauramaa, R.; Hänninen, O. 1988: Physical activity and risk factors for ischaemic heart disease--ten years of research for health improvement Annals of Clinical Research 20(1-2): 58-61
Bojarska, D.; Górski, P.ł 2002: Ischaemic heart disease risk factors in blue-collar women with different level of physical work Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 12(67): 25-29
Vartiainen, E.; Pekkanen, J.; Koskinen, S.; Jousilahti, P.; Salomaa, V.; Puska, P. 1998: Do changes in cardiovascular risk factors explain the increasing socioeconomic difference in mortality from ischaemic heart disease in Finland? Journal of Epidemiology and Community Health 52(7): 416-419
Stober, C.; Clarke, A.; Mulvaney, A.; Harland, J.; Neithercut, W.D. 1994: Cholesterol and lipoprotein(a) as risk factors for coronary heart disease in elderly subjects British Journal of Biomedical Science 51(2): 114-118
Nogués, X.; Sentí, M.; Pedro-Botet, J.; Molina, L.; Serrat, R.; Pons, S.; Rubiés-Prat, J. 1992: Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors Medicina Clinica 98(5): 171-174
Burgio, G.R.; Vaccaro, R. 1972: Immunological remarks on rheumatic fever in children with reference to heart-reactive serum factors, immunoglobulins and 1C -globulin levels Helvetica Paediatrica Acta 27(3): 315-320
Steinmetz, J.; Choukaife, A.; Visvikis, S.; Henny, J.; Siest, G. 1990: Biological factors affecting concentrations of serum LpAI lipoprotein particles in serum, and determination of reference limits Clinical Chemistry 36(4): 677-680
Andersen, L.I. 1996: Prevalence of benign esophageal disease in the Danish population, with special reference to pulmonary disease and risk factors Danish Medical Bulletin 43(3): 263-276
Lamarche, B.; St-Pierre, A.C.; Ruel, I.L.; Cantin, B.; Dagenais, G.R.; Després, J.P. 2001: A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men Canadian Journal of Cardiology 17(8): 859-865
Oganov, R.G.; Tubol, I.B.; Zhukovskii, G.S.; Perova, N.V.; Ilchenko, I.N.; Saava, M.E.; Tur, I.P.; Feizukhanova, D.V.; Nikitin YuP; Dorofeeva, T.G. 1988: Epidemiological characteristics of dyslipoproteinaemia and certain other risk factors of atherosclerosis and ischaemic heart disease in 11- and 14-year children in different climatogeographic zones. Results of a cooperative study Cor et Vasa 30(4): 248-256